Initial results of efficacy and safety of Sofosbuvir among Pakistani Population: A real life trial - Hepatitis Eradication Accuracy Trial of Sofosbuvir (HEATS)

OBJECTIVE: The uridine nucleotide analogue sofosbuvir is a selective inhibitor of hepatitis C virus (HCV) NS5B polymerase approved for the treatment of chronic HCV infection with genotypes 1 – 4. The objective of the study was to evaluate the interim results of efficacy and safety of regimens contai...

Descripción completa

Detalles Bibliográficos
Autores principales: Azam, Zahid, Shoaib, Muhammad, Javed, Masood, Sarwar, Muhammad Adnan, Shaikh, Hafeezullah, Khokhar, Nasir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368328/
https://www.ncbi.nlm.nih.gov/pubmed/28367171
http://dx.doi.org/10.12669/pjms.331.12352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368328/
https://www.ncbi.nlm.nih.gov/pubmed/28367171
http://dx.doi.org/10.12669/pjms.331.12352

Ejemplares similares